Cambridge University Hospitals Nhs Foundation Trust
Clinical trials sponsored by Cambridge University Hospitals Nhs Foundation Trust, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Healthy volunteers help unlock genetic secrets of heart disease Results expected Sep 2026 (estimated)
- New study aims to predict recovery in children with brain injury Results expected Dec 2026 (estimated)
- Wireless monitors for preemies? NHS staff weigh in Results expected Dec 2026 (estimated)
- Weight loss drugs may free young adults from blood pressure meds Results expected Jan 2027 (estimated)
- Could a cancer drug quiet overactive adrenal hormones? a new study investigates. Results expected Apr 2027 (estimated)
-
Could an allergy pill and diabetes drug fix MS nerve damage?
Disease control CompletedThis completed Phase 2 trial tested whether combining two common drugs—metformin (for diabetes) and clemastine (an antihistamine)—can help repair the protective lining of nerve cells in people with relapsing-remitting multiple sclerosis. The 70 participants continued their usual …
Phase 2 • Sponsor: Cambridge University Hospitals NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a vaccine test expose hidden immune weakness?
Knowledge-focused CompletedThis trial tests whether rituximab, a drug used for ANCA-associated vasculitis, leaves patients with a weakened immune system. Researchers give pneumococcal vaccines to patients treated with rituximab, patients with the disease but not on rituximab, and healthy volunteers. They c…
Phase 2 • Sponsor: Cambridge University Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Blood pressure drug response varies by ethnicity, study finds
Knowledge-focused CompletedThis study tested how well different blood pressure drugs work in White, Black, and South Asian people. About 940 adults with high blood pressure took one or two common medicines. The goal was to see if response differs by ethnicity, which could help doctors personalize treatment…
Phase 4 • Sponsor: Cambridge University Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:43 UTC